Company / Cash & Equivalents
Lifevantage Corp Cash & Equivalents History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$16.9M
FY2024
5-year range
$16.9M / $23.2M
FY2020-FY2024
Trend
-21.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has fluctuated over the past 9 years, ranging from $11M in FY2018 to $23M in FY2021.
Based on SEC 10-K filings.
$17M in FY2024 with a 5-year CAGR of -2.1%.
Declined from $20M to $17M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -10.0%
- 5-Year CAGR
- -2.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.1%, indicating a declining trend.
- In FY2024, cash & equivalents decreased 21.8% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
- Lowest cash & equivalents in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $16.9M | -21.8% |
| FY2023 | $21.6M | +7.0% |
| FY2022 | $20.2M | -12.9% |
| FY2021 | $23.2M | +4.7% |
| FY2020 | $22.1M | +17.6% |
| FY2019 | $18.8M | +64.3% |
| FY2018 | $11.5M | -17.6% |
| FY2017 | $13.9M | -31.8% |
| FY2016 | $20.4M | -22.5% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026